T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 103 (2) , 476-480
- https://doi.org/10.1016/0008-8749(86)90108-5
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen?Immunology Today, 1984
- DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984
- IN VIVO ADMINISTRATION OF INTERLEUKIN-2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSESTransplantation, 1983
- Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2Nature, 1982
- IMMUNOLOGICAL MECHANISMS OF GRAFT-VERSUS-HOST DISEASE IN MANTransplantation, 1982
- Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.The Journal of Experimental Medicine, 1982
- Immunogenetics of graft-versus-host reactions to minor histocompatibility antigensImmunology Today, 1981
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978